Informazioni sul prodotto
- S-(Carboxymethyl)-L-cysteine compd. with L-lysine
- (2R)-2-(carboxymethylamino)-3-sulfanyl-propanoic acid
- (2S)-2,6-diaminohexanoic acid
- <span class="text-smallcaps">L</smallcap>-Cysteine, S-(carboxymethyl)-, compd. with <smallcap>L</span>-lysine (1:1)
- <span class="text-smallcaps">L</smallcap>-Lysine, compd. with S-(carboxymethyl)-<smallcap>L</span>-cysteine (1:1)
- L-Lysine S-(Carboxymethyl)-L-Cysteine
- S-(carboxymethyl)-L-cysteine-L-lysine (1:1)
- L-Cysteine, S-(carboxymethyl)-, compd. with L-lysine (1:1)
- L-Lysine, compd. with S-(carboxymethyl)-L-cysteine (1:1)
Applications Fluifort is used in anti-cancer treatment as a selective scavenger of reactive oxygen intermediates.
References Brandolini, L. et al.: Eur. Cyto. Network., 14, 20 (2003); Mantovani, G. et al.: Cancer Epid., Biomark. Prev., 13, 1651 (2004);